BRAIN, FOCUS & MOOD RESEARCH

Selank

A Russian peptide studied for calm focus, stress resilience, and steadier mood.

Selank is a synthetic peptide developed in Russia as an anti-anxiety and cognitive-enhancing compound, built from a natural immune fragment with a calming sequence added. It has a documented Russian clinical-use history and is studied for calm focus, stress resilience, and mood.

Tuftsin AnalogueAnxiolyticNootropicStress Resilience

Why BLP features Selank

Included because it has documented Russian clinical use—material foreign evidence—plus a described neuromodulatory mechanism and a consistent research-use history. Its clinical foundation places it above newer analogues without their own studies.

Mechanism

Modulates GABA and serotonin—the brain's main calming and mood systems—along with the body's own enkephalins.

Raises BDNF, the growth factor behind the formation of new brain-cell connections.

Balances the immune response and lowers IL-6, a key inflammatory messenger; crosses the blood-brain barrier rapidly.

WHAT THE RESEARCH MEASURED

Research findings

Findings describe study outcomes, not expected personal results.

Human research findings

  • Russian clinical research reports calm without sedation.
  • Reported clearer thinking and reduced overthinking, with lower social and performance anxiety.
  • Reported elevated mood and emotional stability, and faster recovery from stress.
  • Considered very well tolerated in research use.

Preclinical findings

  • Neuromodulatory mechanism characterized in neuroscience research.
  • Anxiolytic effects documented in Russian preclinical and clinical work.

Regulatory status

Selank is used clinically in Russia and some other countries but is not FDA-approved. Sold and offered strictly for laboratory and research use.